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Antigen-specific regulatory T cells (Tregs) directed at self-antigens are difficult to
study since suitable specific tools to isolate and characterize these cells are lacking. 
A T cell receptor (TCR)-transgenic mouse would generate possibilities to study such 
 antigen-specific T cells. As was shown previously, immunization with the mycobacterial 
heat shock protein (Hsp) 70-derived peptide B29 and its mouse homologs mB29a
and mB29b induced anti-inflammatory responses. Furthermore, B29 induced antigen- 
specific Tregs in vivo. To study mB29b-specific Tregs, we isolated the TCR from T cell 
hybridomas generated against mB29b and produced a TCR transgenic mouse that 
expresses a MHC-class II restricted mB29b-specific TCR. These TCR transgenic CD4+ 
T cells were found to cross-react with the B29 epitope as identified with peptide-induced 
proliferation and IL-2 production. Thus, we have successfully generated a novel mouse 
model with antigen-specific CD4+ T cells that recognize self and bacterial Hsp 70-derived 
peptides. With this novel mouse model, it will be possible to study primary antigen-specific 
T cells with specificity for a regulatory Hsp70 T cell epitope. This will enable the isolation 
and characterization CD4+CD25+ Tregs with a proven specificity. This will provide useful 
knowledge of the induction, activation, and mode of action of Hsp70-specific Tregs, for 
instance, during experimental arthritis.
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inTrODUcTiOn
Heat shock protein (Hsp) 70 is a ubiquitously expressed protein and plays a role as chaperone in 
protein folding, either after protein synthesis or under conditions of cellular stress (1, 2). Hsp70 is 
evolutionary conserved and is expressed by many species, including bacteria and vertebrates. This 
is reflected by a high degree of homology of Hsp between species. Interestingly, Hsps are also highly 
immunogenic, which might be explained by the fact that Hsps are found in bacteria that surround 
us. However, not only Hsp-derived peptides from bacteria are immunogenic but also peptides 
derived from self-Hsp can trigger immune responses (3, 4). Peptides derived from endogenous 
Hsp70 can not only be found in MHC class I molecules but are also known to be present in MHC 
TaBle 1 | amino acid sequences of hsp70 peptides.
Peptide sequence Protein Origin
mB29a VLRVINEPTAAALAY Hspa9 
(GRP75)
Mus musculus
Homo sapiens
mB29b VLRIINEPTAAAIAY Hspa1a, 
Hspa8
Mus musculus
Homo sapiens
a1a-long29 DAGVIAGLNVLRIINEPTAAAIAYGLDRTGK Hspa1a 
(Hsp72)
Mus musculus
Homo sapiens
a8-long29 DAGTIAGLNVLRIINEPTAAAIAYGLDKK Hspa8 
(Hsp70)
Mus musculus
Homo sapiens
B29 VLRIVNEPTAAALAY DnaK 
(Hsp70)
Mycobacterium 
tuberculosis
The amino acid sequence and origin of the Hsp70-derived peptides used in this study.
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class II (5–8). This indicates that Hsp70-derived peptides can 
be recognized by immune cells in a MHC class II-dependent 
manner. This is supported by experiments in which CD4+ T cell 
responses against Hsp70-derived epitopes have been identified 
after immunization with bacterial Hsp70 (7). Apart from presen-
tation during cellular homeostasis, endogenous Hsp can also be 
presented in MHC when it is upregulated during cellular stress 
such as heat shock (8, 9). Due to the high degree of homology 
of Hsp between species, cross-reactive responses occur in which 
foreign Hsp-peptide reactive T cells can recognize self-Hsp 
peptides (7, 8, 10, 11).
Interestingly, the administration of Hsp70 can result in 
anti-inflammatory responses, which has been shown by the sup-
pression of disease in animal models for chronic inflammation, 
due to activation of Hsp70-specific regulatory T cells (Tregs) that 
are cross-reactive with self-epitopes of Hsp70 (4, 7). Tregs are a 
subset of specialized CD4+ T cells with high suppressive potential 
and are therefore important targets for immune modulation of 
inflammatory diseases (12). Therefore, activating these cells via 
Hsp peptides is a growing field of interest, especially in inflam-
matory diseases in which the disease-inducing antigens are 
unknown.
Previously, we have shown that mycobacterial Hsp70 peptide 
B29 is highly conserved and immunogenic. Immunization with, 
or intranasal administration of B29, activates B29-specific Treg 
in  vivo, which are potent suppressors of experimental arthritis 
(7). Several tools, such as T cell lines and T cell hybridomas, 
have been used to study Hsp-specific T cell responses in the past. 
For instance, T cell lines generated from mycobacterial Hsp60 
immunized rats specific for a highly conserved sequence of Hsp60 
have been used to study the suppressive potential of Hsp-specific 
T cells (10). Similar results were obtained with T cell lines gener-
ated from mycobacterial Hsp70 immunized rats: Hsp70-specific 
T cells reduced the severity of arthritis in the experimental arthritis 
model (13). However, none of these systems allows the evaluation 
of primary T cell responses (in  vivo), the behavior of Hsp70-
specific Tregs upon activation, or the induction of particular 
T cell subsets such as effector T cells and Tregs after administration 
of Hsp70. Especially, antigen-specific Tregs are difficult to study 
since these cells comprise only a small fraction of the total T cell 
population and are difficult to culture and maintain in vitro (14).
Therefore, we aimed to generate a mouse model to study pri-
mary and naive Hsp70-specific CD4+ T cells in more detail. For 
that reason, we isolated the T cell receptor (TCR)-α and TCR-β 
chain genes from a T cell hybridoma generated against peptide 
mB29b, a mammalian homolog of B29 (Table 1). This hybridoma 
was found to cross-react with B29 and another mammalian 
homolog: mB29a (9). With the TCR-α and TCR-β chain genes, we 
generated a TCR transgenic mouse with Hsp70 peptide-specific 
CD4+ T cells. We show that CD4+ T cells from the mB29b-TCR 
transgenic mouse undergo antigen-specific proliferation and 
produce IL-2 after restimulation with B29 or its mouse homologs. 
In future studies, primary CD4+ T cell responses directed against 
self and bacterial Hsp70 peptides can be investigated in vitro and 
in vivo. Particularly, the activation and differentiation of antigen-
specific CD4+ Tregs can be studied with this model, which are not 
possible with long-term T cell lines or T cell hybridomas.
MaTerials anD MeThODs
Mice, Peptides, and antibodies
Female Balb/c mice aged 8–12  weeks were purchased from 
Charles River and used as cell donors to create hybridomas and 
as source of APCs for coculture assays. Animals were kept under 
standard conditions at the animal facility, and all experiments 
were approved by the Animal Experiment Committee of Utrecht 
University. Mice strains used for the generation of the mB29b-
TCR transgenic mouse were F1 of (CBA  ×  C57BL/6) mice 
(Charles River). Hsp70-derived peptides (mB29a, mB29b, B29) 
were identified previously (7) and were obtained from GenScript 
Corporation. The amino acid sequences and origin of the pep-
tides are shown in Table 1. Anti-MHC-II (I-Ad/I-Ed) antibody 
(clone M5/114) 5 μg/ml; gift from Louis Boon from Bioceros B.V., 
Utrecht, The Netherlands was used to block  MHC-II-peptide 
TCR interactions in cocultures. To stain mB29b-specific cells, 
an APC-labeled murine – mB29b-specific tetramer that is com-
posed of mB29b [VLRIINEPTAAAIAY linked to I-A(d)(BALB/c 
haplotype-matched MHC class II molecule)] was used for 90 min 
at 20  μg/ml. This tetramer is a gift from NIH Tetramer Core 
Facility (Emory University, Atlanta, GA, USA).
generation of mB29b-Tcr hybridoma 
(lhePs)
CD4+ T cell hybridomas (named LHEPs) were generated against 
Hsp70 peptide mB29b in our laboratory, as described previously 
(9). Activation of specific hybridoma clones by mB29b was 
addressed by incubating hybridoma cells (2 × 104/well) with irra-
diated (10,000 rad) A20 B lymphoma cells as APC (2 × 104/well) 
loaded with Hsp70 peptides in 96 wells flat bottom plates for 48 h 
and pulsed with 3H-thymidine (0.4 μC/well) for an additional 
16 h to measure activation-induced cell death (AICD).
As a positive control, hybridomas were stimulated with 
2 μg/ ml ConA. After 48 h coculture, supernatants were harvested 
and frozen at −20°C. IL-2 production by hybridomas was studied 
by culturing the harvested supernatants with IL-2 responder 
 CTLL-16 cells (cytotoxic T cell line; 5 × 103/well) for 24 h. The 
CTLL-16 cells were pulsed with 3H-thymidine (0.4  μC/  well) 
for another 16  h (Amersham Biosciences Europe GmbH, 
Roosendaal, The Netherlands). The 5/4E8 hybridoma specific for 
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proteoglycan (PG)-derived peptide PG70-84 (15) was used as a 
control. RNA from the mB29b-TCR hybridoma was sequenced to 
determine the TCR usage. Sequencing revealed that the isolated 
mB29b TCR consisted of Vα 7 (TRAV-7.01-J26.01 in the IMGT 
nomenclature) and Vβ 8.2. The Vβ 8.2 is according to the NCBI 
nomenclature, this correlates with TRBV-13-2.01-D2.01-J2-7.01 
in the IMGT nomenclature.
Mhc restriction of T cell hybridomas
The MHC restriction of the peptide mB29b-specific hybridomas 
was determined using mouse anti-I-Ad (BD PharMingen) mAb. 
Hybridoma cells were cultured with A20 APCs in the presence 
of 0.5 μg/ml peptide mB29b and anti-I-Ad mAb (MKD6) at a 
concentration of 20 μg/ml. The effect of mAb on IL-2 production 
was determined with the CTLL-16 bioassay, as described above.
cloning of the αβ Tcr
Total RNA was isolated from the mB29b-TCR hybridoma cells by 
extraction with RNAzol (Invitrogen). The oligo(dT)12–18 primer 
from the Superscript Reverse Transcription kit (Invitrogen) was 
used for reverse transcription of the isolated RNA. To express the 
TCR mB29b genes in the transgenic mice, we cloned the Vα and 
Vβ genes into pTα and pTβ cassettes obtained from Kouskoff et al. 
(16). Isolation of genomic DNA from the mB29b-TCR hybridoma 
was performed to obtain full length rearranged TCRα and TCRβ 
DNA, including leader and intron sequences. mB29b-TCR DNA 
was amplified by PCR using the primer for the Vα chain (Forward: 
TRAV7-1-Xmal: TAATCCCGGGAGAATGAAGTCCTTGT 
GTGTTTCAC, Reverse; TRAJ26.01-Notl: TAATGCGGCCGC 
ACAGTAGACCTCAGGTCCCCCTCAC) and the Vβ chain 
(Forward: TRBV13-2.-1-Xhol:TAATCTCGAGAAGATGGGCT 
CCAGGCTCTTC; Reverse:TRBJ2-7.01-SacII: TAATCCGCGGCC 
TGGTCTACTCCAAACTACTCC). The PCR products of the two 
fragments were cloned using TA overhang into the pGEM-T easy 
vector (Promega). The constructs were subsequently introduced 
into E. coli DH5α. The XmaI and NotI released DNA fragment, 
containing the TCRα chain, was cloned into the pTα cassette. The 
XhoI and SacII DNA fragment, containing the TCRβ chain, was 
cloned into the pTβ cassette. Both were transfected into XL10 
gold cells (Stratagene) by electroporation.
In Vitro expression of the αβ Tcr
The pTα cassette, the pTβ cassette, and the pcDNA3 plasmid 
(containing neomycin resistance gene) were electroporated into 
the mouse 58α−β− T cell hybridoma that lacks functional TCR 
chains (17). Transfected cells were cloned using limiting dilution 
in 96 wells plates using the FACS Vantage (BD) and cell lines 
were cultured in the presence of Geneticin 418 (0.8  mg/ml). 
PCR was used to validate DNA incorporation and transfected 
cells were tested for antigen specificity in a similar manner as the 
 hybridomas (described above).
generation of the mB29b-Tcr  
Transgenic Mouse
T cell receptor transgenic mice were generated in our laboratory, 
as described previously (15, 17, 18). The pTα mB29b-TCR and the 
pTβ mB29b-TCR plasmids were linearized using SalI (pTα) and 
KnpI (pTβ). Via pronuclear injection a mixture of the plasmids were 
introduced into fertilized eggs of F1 (CBA × C57BL/6) mice. Two 
mB29b-TCR transgenic founders were identified by PCR analysis 
of genomic DNA (same primers as described above). Founder 2 
was mated with Balb/c mice (Balb/cBYJRj; Jackson laboratories), 
and offspring was tested for peptide specificity, as described below.
Measurement of antigen-specific T cell 
responses from mB29b-Tcr Mice
Blood was taken from founders and depleted from erythrocytes 
with ACK lysis buffer (H2O containing 150 mM NH4Cl, 10 mM 
KHCO3, and 0.1 mM EDTA, pH 7.2–7.4). Blood cells (founder 
1: 1 × 105, founder 2: 5 × 105, depending on cell yield after blood 
collection) were cultured for 96 h with 1 × 106 irradiated A20 cells 
as APCs. Cells were stimulated with 2 or 20 μg/ml B29 or with 
5 μg/ml ConA as a positive control. Peripheral blood lymphocytes 
(PBLs) from founders were tested for antigen-specific responses 
to 2 or 20 μg/ml mB29a, mB29b, or B29 peptides. Proliferation 
was determined by 3H-thymidine incorporation during the final 
16 h of culture, and IL-2 production was determined by Luminex. 
Splenocytes from offspring were screened for the expression of 
TCRα and TCRβ chain. The mB29b-TCR positive splenocytes 
were also tested for antigen specificity.
Flow cytometric analysis
Single cell suspension of splenocytes, lymph node cells, or 
thymocytes were made, and these were stained with antibod-
ies CD3-APC (OKT-3, BD Biosciences), CD4-V450 (RM4-5, 
eBioscience), CD8-V500 (RPA-T8, BD Biosciences company), 
Vβ8-PE (F23.1, BD Biosciences) KI-67-PerCp-Cy5.5 (BD56, BD 
biosciences), CD25-PerCp-Cy5.5 (PC61.5, Ebioscience), IFN-γ-
FITC (XMG1.2, BD biosciences), CD44-APC (IM7, ebioscience), 
CD62L-FITC (MEL-14, BD biosciences) or FoxP3-eFluor450 
(FJK-16s,  ebioscience) and incubated for 30 min at 4°C. Cells 
were washed three times with PBS containing 2% FCS. Cells were 
acquired on the FACS Canto II (BD) and analyzed with FlowJo 
7 (Tree Star). For cell activation experiments, splenocytes from 
transgenic mice or littermates were cultured (1 × 105 cells/well) 
for 24 h in the presence of 20 μg/ml mB29b, in which the last 4 h 
was in the presence of 1 μg/ml Brefeldin A.
histology
For histology, thymus, spleen, inguinal lymph nodes (iLN; repre-
sentative draining LNs), and liver were isolated from mB29b-TCR 
positive mice, or negative littermates. Tissues were fixed in 10% 
neutral buffered formalin, embedded in paraffin, and 5 μm sag-
gital sections were stained with hematoxylin and eosin (H&E). 
Immunohistochemistry was performed to T cells and general pro-
liferation in lymphoid tissues. Briefly, cryosections (5 μm) were 
fixed in ice-cold acetone and blocked against endogenous per-
oxidase with 0.3% hydrogen peroxide in methanol. Non-specific 
staining was blocked with a 1% BSA solution, and sections were 
incubated with primary antibodies against CD3 (BD Biosciences) 
or Ki-67 (BD Biosciences). Secondary staining was performed 
with an anti-rat HRP antibody (Millipore), and Peroxidase activ-
ity was developed using the DAB Peroxidase Substrate kit (Vector 
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FigUre 1 | The hybridoma lheP4 recognizes hsp70 peptides mB29a, mB29b, and B29 in an Mhc class ii restricted way. Splenocytes from BALB/c 
mice immunized with mB29b were fused with BW5147 cells, which resulted in mB29b-specific CD4+ T cell hybridoma clones (LHEPs). (a) Activation-induced cell 
death (AICD) is measured by reduced thymidine incorporation upon activation with mB29a, mB29b, and B29. MHC-II blockage results abrogate AICD, which 
indicate that the mB29b-TCR hybridomas are MHC-II restricted. (B) IL-2-dependent CTLL-16 proliferation was measured to demonstrate that supernatant of 
activated hybridomas as depicted in (a) produce IL-2. As shown in (B), IL-2 production is present after stimulation with mB29a, mB29b, and B29. MHC-II blockage 
results in a diminished IL-2 production. As a positive control, cells were stimulated with ConA. As a negative control, LHEP4 hybridoma cells were cultured in 
medium only, in the presence of mB29b (no APC). Additional controls included A20 cells cultured with mB29b, or the 5/4E8 hybridoma cultured in the presence of 
mB29b peptide. 3H-thymidine incorporation is shown as mean of triplicate samples/well ± SEM. Data shown are representative of three independent experiments.
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Laboratories). Sections were counterstained with hematoxylin and 
mounted with Aquatex (Merck, Darmstadt, Germany). Pictures 
were taken using an Olympus BX41 microscope and analyzed 
with Cellsens entry 1.9 software (Olympus Corporation).
statistics
Unless stated otherwise, data are expressed as mean  ±  SD. 
Statistical analyses were carried out using Student’s t-test or 
the two-way ANOVA test using Prism software (Version 6.05). 
p ≤ 0.05 was considered significantly different.
resUlTs
Mhc class ii restricted recognition of 
hsp70 Peptides mB29a, mB29b, and B29 
by mB29-Tcr hybridoma lheP4
T cell hybridomas specific for Hsp70 peptide mB29b were gen-
erated by immunizing BALB/c mice with the peptide mB29b 
and fusing splenocytes from these mice with BW5147 cells 
followed by limiting dilution to obtain individual clones of the 
mB29b-TCR hybridomas. In order to test the TCR specificity 
of the generated hybridomas, which we named LHEPs, the cells 
were cultured in the presence of A20 cells as APCs and peptide 
mB29b, or its homologs mB29a and B29 (Figure 1). AICD and 
IL-2 production (9), two characteristics of an activated hybri-
doma, were measured for seven LHEPs. The AICD was deter-
mined by 3H thymidine incorporation, and the IL-2 production 
was measured by IL-2-dependent proliferation of the CTLL-16 
cell line. Data of LHEP4 are depicted as a representative example 
in Figure  1. As seen in Figure  1, stimulation of LHEP4 with 
mB29a, mB29b, and to some extend with B29 resulted in cell 
death and IL-2 production. To determine whether recognition 
of Hsp70 peptides was MHC class II restricted, LHEPs were 
stimulated with peptide in the presence of an MHC class II 
blocking antibody. In this case, no AICD and a strongly reduced 
IL-2 production was seen upon stimulation with Hsp70 peptides, 
indicating that peptide recognition of mB29b-TCR hybridomas 
was indeed MHC class II restricted (Figures 1A,B). The mB29b 
peptide was presented in the context of I-Ad molecules, since a 
mAb against I-Ad (MKD6) completely abrogated the mB29b-
specific in vitro proliferation of the LHEP4 hybridoma (data not 
shown).
Screening of the obtained selected mB29b-specific T cell 
hybridomas revealed seven LHEPs in total that were responsive 
to mB29b, of which five were cross-reactive to mB29a, and four 
that were cross-reactive to B29.
lhePs respond to several length 
Variants of the hsp70 Peptide
We next determined a dose response of LHEP4 to the Hsp70 
peptides, as well as recognition of specific length extension vari-
ants of mB29b to assess the response to processed peptides. For 
this, LHEP4 was cocultured with irradiated splenocytes in the 
presence of the extended hspa8 (=Hsc70) or hspa1a (=Hsp72) 
(19) variants of the mB29b peptide, later referred to as a8-long29 
and a1a-long29. CTLL-16 proliferation induced by IL-2 produc-
tion from LHEP4 indicated that these length variants could be 
recognized (Figure  2A). Although IL-2 production decreased 
in cultures in which LHEP4 was stimulated with low amounts 
of mB29b or B29 (data not shown), CTLL-16 proliferation 
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FigUre 2 | The mB29b-Tcr hybridoma lheP4 produces antigen-specific il-2 upon coculture with primary antigen-presenting cells. (a) LHEP4 was 
cocultured with irradiated splenocytes loaded with different concentrations [ranging from 5, 0.5, to 0.05 μg/ml, as well as 10 μg/ml length variants of mB29b 
(hspa8 = Hsc70 or hspa1a = Hsp72)] (20) of Hsp70 peptides as indicated, after which supernatants were collected. CTLL-16 cell cultures were supplemented with 
supernatants from these stimulations to determine IL-2-dependent proliferation of CTLL-16 cells. As a control, cocultured LHEP4 cells were unstimulated, or 
stimulated with ConA. 3H-thymidine incorporation is shown as mean of triplicate samples/well ± SEM. Data shown are representative of three independent 
experiments. (B) mB29-TCR hybridomas were stimulated with Hsp70 peptides mB29a, mB29b, or B29, as well as length variants of mB29b [hspa8 = Hsc70 or 
hspa1a = Hsp72 (20), as described in (a)]. The + symbol (cpm >15,000) indicates AICD and IL-2 production upon coculture with supernatants from peptide-
stimulated LHEPs. Weak responses are depicted as ± (on average the cpm = 4000). Medium stimulated samples show on average a cpm of 1500. Data shown 
summarize three independent experiments.
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remained detectable, indicating that LHEP4 responds sensitively 
to presented Hsp70 peptides (Figure 2A).
Apart from LHEP4, the previously selected T cell hybridomas 
were screened for the recognition of Hsp70 peptide (length vari-
ants) (Figure 2B). All LHEPs responded to the mB29b peptide 
when presented by different primary APC, indicating that the 
mB29b-TCR hybridomas recognize Hsp70 peptides presented 
by APCs from various sources (data not shown). As was previ-
ously seen (Figure  2B), not all LHEPs were cross-reactive to 
other peptides, including the length variants of mB29b (hspa8 
or hspa1a). All mB29b-TCR hybridomas that recognize different 
length variants of mB29b provide a broad recognition spectrum.
cloning of the Tcrα and Tcrβ chain from 
mB29b-Tcr hybridoma lheP4 into  
Tcr− cells results in hsp70  
Peptide-specific Transfectants
Based on the specificity and the strong cross-reactive responses 
of LHEP4, the TCRα and TCRβ chain of this mB29b-TCR 
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FigUre 3 | cloning of the Tcrα and Tcrβ chain from mB29b-Tcr hybridoma lheP4 into Tcr− cells results in hsp70 peptide-specific transfectants. 
Cloned transfected cells were cocultured with A20 B cells (a) or BMDCs (B), which were loaded with 5, 0.5, or 0.05 μg/ml Hsp70 peptides. After stimulation with 
Hsp70 peptides mB29a, mB29b, or B29, as well as length variants of mB29b (a1a or a8), supernatants were added to CTLL-16 cells and IL-2-dependent 
proliferation was determined after 24 h. The graph shows more IL-2-dependent proliferation of CTLL-16 cells when stimulated with a high concentration Hsp70 
peptide mB29b or B29. There is no response to stimulation with mB29a and to a minor extent to the length variants of mB29b (a8 or a1a). Similar results were 
obtained with the BMDC coculture (B). As a control, cocultured LHEP4 cells were unstimulated or stimulated with ConA (data not shown). 3H-thymidine 
incorporation is shown as mean of triplicate samples/well ± SEM. Data shown are representative of two independent experiments.
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hybridoma were cloned into TCR expression vectors, which were 
transfected into cells lacking the TCR (TCR−). The transfected 
cell line was cocultured with BMDC or irradiated A20 B cells, 
which were loaded with Hsp70 peptides to confirm the antigen 
specificity of the transfectant. Results showed a dose-dependent 
response to mB29b and B29, but not to mB29a (Figure  3). 
Irradiated thymocytes and splenocytes were also used as APC 
and gave similar proliferative responses (data not shown). 
Furthermore, addition of shorter variants of the mB29b pep-
tide to LHEP4 and the transfected cells, failed to stimulate the 
mB29b-specific hybridoma and cells indicating the specificity of 
the hybridoma and transfected cells (data not shown). Together, 
these data confirmed that the TCRα and TCRβ chain were 
successfully cloned into TCR expression vectors, and therefore 
we transferred the TCRα and TCRβ chain constructs to mouse 
oocytes via pronuclear injection.
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FigUre 4 | antigen recognition by mB29b-Tcr transgenic mouse. PBLs from two founders, positive for the TCRα and TCRβ chain, were cultured for 96 h 
with irradiated A20 B cells and stimulated with 2 or 20 μg/ml B29, or 5 μg/ml ConA as a positive control. PBLs from founder 2 proliferated in a dose-dependent 
response. The PBLs from founder 1 did not show any proliferation after B29 stimulation. The PBLs from both founders produced IL-2 but the PBLs from founder  
2 produced higher amounts. Proliferation was determined by 3H-thymidine incorporation during the final 16 h of culture and IL-2 production was determined by 
Luminex. Data are from one experiment.
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antigen recognition of cells from  
mB29b-Tcr Transgenic Mouse
After pronuclear injection of the DNA expressing TCRα and 
TCRβ into the donor zygote, the zygote was injected in a foster 
mouse from which several pups were born that had incorporated 
the constructs. From these mice, two founders were positive for 
both constructs with PCR (data not shown). PBLs from the two 
founders were stimulated with B29 in a coculture with irradiated 
splenocytes. PBLs from one founder proliferated and produced 
IL-2 in response to B29 stimulation (Figure 4). Next, the positive 
founder was mated with Balb/c mice and F1 mice were screened 
for the expression of the TCRα and TCRβ chain and splenocytes 
from mB29b-TCR positive offspring were tested for antigen 
specificity and compared to negative littermates. We observed 
responses to mB29b, B29, and mB29b length variant (a8) long29 
(Figure 2B), while mB29b-TCR negative littermates showed no 
response to any of the peptides tested (data not shown). These 
data show that we successfully generated mB29b-TCR transgenic 
mice with cells with a functional TCR that recognized Hsp70 
peptides.
Flow cytrometric analysis of mB29-Tcr 
Transgenic Mouse Tissues
Next, we examined the presence of CD3+, CD4+, CD8+ T cells 
in thymus of the mB29b-TCR transgenic mouse. Since the 
mB29b-TCR hybridoma was recognized by the antibody directed 
against Vβ8, we also screened the thymus for Vβ8+ T cells. The 
transgenic mice and littermates had a similar frequency of CD4+ 
cells, whereas the transgenic mouse had an increased percentage 
of Vβ8+ T cells in the thymus and a decreased amount of CD8+ 
cells (Figure  5A). In the spleen, the same differences in CD4+  
T cell and CD8+ T cell distribution (more CD4+ T cells compared 
to a wild type mouse) were observed, as well as an increased 
 number of Vβ8+ T cells were detected (Figure 5B). This resulted 
in changes in the CD4:CD8 ratio in both the thymus and spleen. 
The increased CD4:CD8 ratio became more evident in later 
generations. We observed a similar distribution and percentage 
of T cells in the LN (data not shown). To test the specificity of 
the CD4+ T cells in the mB29b-TCR Tg mouse, we stained sple-
nocytes with an APC-labeled murine – mB29b-specific tetramer 
that is composed of mB29b [VLRIINEPTAAAIAY linked to 
I-A(d)] and also cultured splenocytes in the presence of mB29b 
for 24 h. As shown in the lower part of Figure 5B, the mB29b TCR 
Tg mouse contains more tetramer-specific CD4+ T cells than the 
WT Balb/c and the negative littermate. Figure 5D demonstrates 
that after 24 h of culture in the presence of mB29b, more CD4+  
T cells are activated (IFN-γ and CD25 expression) in the spleen of 
the transgenic mouse, in comparison with the negative littermate. 
Furthermore, also the CD4+CD25+FoxP3+ population is more 
pronounced in the mB29b TCR Tg mouse compared to the nega-
tive littermate, while in naive mice, FoxP3 expression is lower in 
mB29b Tg mice (Figure 5C).
mB29b-Tcr Transgenic Mice show an 
increase in naive cells
To investigate cell distribution and activation, both histology and 
flow cytometry were used. Tissue sections from thymus, spleen, 
iLN, and liver were made and stained for H&E or CD3 (Figure 6). 
Based on the H&E stained tissue slides, no apparent changes are 
observed in iLN, spleen, thymic, or liver tissue architecture (data 
not shown). In addition, the distribution of CD3+ T cells in the 
different lymphoid tissues was comparable between the TCR 
transgenic mouse and the littermate (Figure 6A). However, we 
did find a difference in proliferative activity, as based on the Ki-67 
expression in splenocytes (Figure 6B). The KI-67 positive popu-
lation is reduced in the mB29b TCR Tg mouse when compared to 
the wild type mice and negative littermates. This correlates with 
the enhanced non-proliferative naive cell population (defined 
as CD62LhiCD44low) in naive mB29b TCR Tg mice (Figure 6B). 
Overall, histological analysis revealed no major differences in 
Thymus 
Transgenic mouse  A non transgenic littermate   
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T cell distribution or activation between the founder and control 
littermates in lymphoid organs, suggesting no development of 
gross pathology.
DiscUssiOn anD cOnclUsiOn
Investigating Hsp-specific T cell responses in vivo and in vitro is 
of great interest to examine the effect of Hsp administration on T 
cell activation and differentiation. Although there are Hsp-specific 
cell lines that have been generated after long in vitro culture (10, 
20), as well as Hsp-specific T cell hybridomas (9), these cells lack 
the properties of primary T cells. A huge disadvantage of these 
cells is that they lack the ability to differentiate from naive cell 
to effector or Treg and can therefore only be used for qualitative 
analysis of Hsp recognition. Several studies have shown that the 
immunomodulatory effect of Hsp administration (being immu-
nization, intranasal administration, or oral administration) is due 
to the activation of Hsp-specific Tregs (7, 21–23). However, little 
is still known about the function of these cells. For instance, it 
is difficult to study Tregs in vitro, since these cells require more 
than peptide stimulation alone (e.g., growth factors like IL-2 
and/or TGF-β) for their expansion and differentiation (24, 25), 
in comparison to immortalized T cell lines. Eventually, one would 
like to study primary antigen-specific T cells; however, these are 
only a minor population within the total population of T cells. 
Therefore, a TCR transgenic mouse is a valuable tool to obtain 
larger quantities of antigen-specific T cells. As a result, we set out 
to generate a TCR transgenic mouse with Hsp70 peptide-specific 
T cells to establish a tool to study the activation, differentiation, 
and suppressive capacity of Hsp-specific T cells.
In this study, we have successfully cloned an mB29b-TCR 
hybridoma with specificity for the Hsp70 peptide mB29b. Due to 
sequence homologies of Hsp70 family members, this hybridoma 
can recognize self-Hsp peptides mB29a and mB29b, and the 
FigUre 5 | cD4+ and cD8+ T cell distribution in tissues of mB29-Tcr transgenic mouse. (a) Single cell suspensions were made from thymus of 
mB29b-TCR transgenic mice or negative littermates. Cells were stained for the expression of CD3, CD4, CD8, and Vβ8. Live cells were gated on the forward scatter 
(FSC) and side scatter (SSC) and the percentage of CD4+ and CD8+ cells of the live cells are depicted in the upper panel of (a). In the lower panel of (a), the 
percentage of CD4+Vβ8+ of all live cells is shown. The different CD4+ and CD8+ T cell distribution of the mB29b-TCR transgenic mouse compared to non-transgenic 
littermates is due to the transgenic background, in which formation of T cells is changed. Plots shown are representatives of three independent experiments.  
(Continued)
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mycobacterial Hsp70 peptide B29. Recognition was MHC class 
II dependent, and all APCs tested were capable of activating the 
mB29b-TCR hybridoma (Figures 1 and 2). Next, the TCRα and 
TCRβ chain were isolated and cloned into TCR expression vec-
tors, which were electroporated into TCR− T cells, which showed 
peptide-specific activation upon electroporation of the construct 
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FigUre 5 | (B) Distribution of CD4+ and CD8+ cells in the CD3+ cells (left row of graphs), histograms of CD4+ cells (middle row of graphs) and CD8+ cells (right row 
of graphs) of total CD3+ cells are depicted. The transgenic mouse shows an increase in CD8+Vβ8+ and CD4+ Vβ8+ T cells compared to the non-transgenic littermate. 
The overlay histogram at the bottom of (B) represents the amount of mB29b-specific CD4+ T cells in a WT Balb/c (filled gray), a negative littermate (dashed line), and 
an mB29b TCR Tg mouse (black line). The dotted line shows splenocytes stained with a CLIP tetramer as negative control. Each line represents three different mice.  
(Continued)
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FigUre 5 | (c) CD25 and FoxP3 expression measured within de CD4+ population of splenocytes derived from naive mice. (D) CD25, IFN-γ, and FoxP3 markers 
are measured by flow cytometry upon 24 h culture of splenocytes from both negative littermates as transgenic mouse in the presence of mB29b.
(Figure  3). Although the hybridomas did show a response to 
mB29a (Figures  1 and 2), the TCR− cells in which the expres-
sion vectors from hybridoma LHEP4 were transfected showed 
little response to this peptide as measured by IL-2 production. 
This can be explained by the fact that hybridomas produce much 
larger amounts of IL-2 in response to antigen-specific stimulation 
compared to the TCR− cells. In addition, the mB29a peptide was 
found to be a less strong agonist than the founding peptide mB29b 
when used to stimulate splenocytes from the mB29b TCR Tg 
mouse, most likely due to the two amino acids difference (Table 1).
After linearization of the mB29b-TCR plasmids, the TCRα 
and TCRβ chain were injected pronuclear into mouse oocytes. 
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FigUre 6 | mB29b-Tcr transgenic mouse shows no pathological changes in histology. (a) Thymus, inguinal lymph nodes (iLN), and liver (data not shown) 
were isolated from mB29b-TCR positive mice, or negative littermates. (a) shows sections of the spleen in which no structural changes were observed between the 
mB29b-TCR transgenic mouse and the non-transgenic littermate. Immunohistochemistry was performed to T cells (αCD3) and general proliferation in lymphoid 
tissues. The distribution of CD3+ T cells in the mB29b-TCR transgenic mouse does not deviate from the non-transgenic littermate. Pictures show the spleen in a  
4× magnification. (B) Splenocytes were isolated from naive wild type Balb/c, mB29b TCR Tg mice and negative littermates and CD4+ cells were stained for KI-67 or 
CD44 and CD62L. Data are obtained by flow cytometry. Data are shown as mean of triplicate samples/well ± SEM. Data shown are representative of two 
independent experiments.
Two founders were born that carried both vectors. PBLs from 
one of the mB29b-TCR transgenic founders showed mB29b-
specific activation, as well as cross-recognition to the Hsp70 
peptide B29 (Figure  4). This founder (founder 2) was mated 
with Balb/c mice and offspring was screened for bearing the 
mB29b-TCR. Splenocytes were stimulated with Hsp peptides 
and showed similar peptide recognition as the founder did. 
FACS analysis revealed that the distribution of CD4+ and CD8+ 
T cells in thymus and spleen of the mB29b-TCR transgenic were 
slightly different to that of littermates (Figure  5). Differences 
in CD4+ and CD8+ T cell distribution in TCR transgenic mice 
compared to non-transgenic littermates is due to the transgenic 
background in which formation of T cells is altered. This is 
considered normal for a TCR transgenic mouse (26, 27), since 
these mice will have selective development of αβTCR T cells in 
the thymus. The distribution of TCR transgenic cells could be 
seen in histology of the thymus (Figure 6). Although, in general, 
the T cell distribution in the tissue sections was comparable 
between the mice, a decreased CD4+CD25+FoxP3+ population 
was observed in naive mB29b TCR transgenic mice by flow 
cytometry, comparable to several other TCR transgenic mice 
(28, 29). Furthermore, the amount of proliferated cells was 
altered in lymphoid tissues from the mB29b-TCR transgenic 
mouse compared to littermates. The mB29b-TCR Tg mice 
showed a decrease in KI-67+ cells, which might be due to the 
fact that mB29b is a self-peptide which causes self-regulation. 
The data do indicate that tissue morphology is normal in the 
mB29b-TCR transgenic mouse. Furthermore, no spontaneous 
autoimmune disease was observed in these young TCR trans-
genic mice.
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